Filing Details

Accession Number:
0001104659-18-055379
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-09-05 17:04:17
Reporting Period:
2018-09-01
Accepted Time:
2018-09-05 17:04:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1491576 Tesaro Inc. TSRO Pharmaceutical Preparations (2834) 272249687
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1699305 Orlando Oliveira C/O Tesaro, Inc.
1000 Winter Street
Waltham MA 02451
Svp & Gm, International No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-09-01 1,250 $0.00 10,326 No 4 M Direct
Common Stock Disposition 2018-09-04 72 $32.44 10,254 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2018-09-01 1,250 $0.00 1,250 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,250 No 4 M Direct
Footnotes
  1. This sale was effected in accordance with the terms of the underlying restricted stock unit award agreement and a 10b5-1 Trading Plan entered into by the Reporting Person and was made in order to pay the tax liability arising from the vesting of the restricted stock units.
  2. Each restricted stock unit represents a contingent right to receive one share of TESARO common stock.
  3. The restricted stock units were granted on September 1, 2015 and vest in four equal annual installments beginning September 1, 2016.